# Eplerenone, ACE Inhibition and Albuminuria

> **NCT00315016** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** eplerenone
- **DRUG:** fosinopril
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00315016
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315016, "Eplerenone, ACE Inhibition and Albuminuria". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00315016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*